Artificial Intelligence Is Transforming Pap Test Screening
Labcorp’s adoption of artificial intelligence technology aims to enhance the screening process for cervical cancer.
Read MorePosted by Chris Wolski | Oct 14, 2024 | Cervical (HPV) |
Labcorp’s adoption of artificial intelligence technology aims to enhance the screening process for cervical cancer.
Read MorePosted by Chris Wolski | Oct 11, 2024 | Molecular Diagnostic Analyzers |
Two case studies illustrate how a newly developed sepsis test improves turnaround times and diagnostic accuracy.
Read MorePosted by Andy Lundin | Oct 11, 2024 | Sequencing Systems |
Illumina’s new MiSeq i100 Series sequencing systems provide faster, simpler, and more cost-efficient next-generation sequencing solutions.
Read MorePosted by Andy Lundin | Oct 10, 2024 | Sexually Transmitted Diseases |
Labcorp has expanded its STI testing options with an FDA-authorized OTC blood test for syphilis that provides rapid results.
Read MorePosted by Andy Lundin | Oct 9, 2024 | Molecular Diagnostics |
Delve Bio partnered with Broad Clinical Labs to accelerate commercialization and accessibility of mNGS for diagnosing neurological infection.
Read More